Advertisement

Topics

BryoLogyx Company Profile

07:20 EDT 20th March 2019 | BioPortfolio

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus is on cancer, where it capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the immune response unleashed by cancer immunotherapy; and the invention of the first practical synthetic production method for bryostatin and analogs, enabling their availability for commercial development. BryoLogyx has exclusive rights from Stanford University to the method’s use in the areas of cancer and HIV. Bryostatin, currently in development for use with immuno-oncology agents, has an established safety profile based on clinical studies involving more than 1100 patients. Learn more at www.bryologyx.com


News Articles [2 Associated News Articles listed on BioPortfolio]

BryoLogyx licenses Stanford's synthetic bryostatin-1 IP for cancer, HIV indications

BryoLogyx Inc. exercised an option (apparently first entered into in 2017) to license exclusive worldwide rights to Stanford University's synthetic bryostatin-1 and bryostatin analogs (known as bryolo...

BryoLogyx Acquires Rights from Stanford University for Bryostatin and Analogues, for Development as Possible Treatment for Cancer And HIV

License Encompasses Related Synthesis of Rare Marine-based Molecule; and Broad Potential Therapeutic Utility BryoLogyx, a privately held company focused on improving on surviv...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

BryoLogyx

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus...

More Information about "BryoLogyx" on BioPortfolio

We have published hundreds of BryoLogyx news stories on BioPortfolio along with dozens of BryoLogyx Clinical Trials and PubMed Articles about BryoLogyx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BryoLogyx Companies in our database. You can also find out about relevant BryoLogyx Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record